ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MATK Martek Biosciences Corp. (MM)

31.49
0.00 (0.00%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Martek Biosciences Corp. (MM) NASDAQ:MATK NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 31.49 0 01:00:00

CORRECTING and REPLACING The Law Firm of Levi & Korsinsky, LLP:

21/12/2010 5:08pm

Business Wire


Martek (NASDAQ:MATK)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Martek Charts.

First graph, second sentence should read: Under the terms of the transaction, Martek stockholders will receive $31.50 in cash for each outstanding share of Martek stock they own for a total transaction value of approximately $1.09 billion. (sted Under the terms of the transaction, DSM stockholders will receive $31.50 in cash for each outstanding share of DSM stock they own for a total transaction value of approximately $1.09 billion.)

The corrected release reads:

THE LAW FIRM OF LEVI & KORSINSKY, LLP LAUNCHES AN INVESTIGATION INTO THE POSSIBLE BREACHES OF FIDUCIARY DUTY BY THE BOARD OF MARTEK BIOSCIENCES CORPORATION IN CONNECTION WITH THE SALE OF THE COMPANY TO ROYAL DSM N.V. – MATK

Levi & Korsinsky is investigating the Board of Directors of Martek Biosciences Corporation (“Martek” or the “Company”) (NasdaqGS: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Royal DSM N.V. (“DSM”) (NYSE: DSM). Under the terms of the transaction, Martek stockholders will receive $31.50 in cash for each outstanding share of Martek stock they own for a total transaction value of approximately $1.09 billion.

Click here to learn how to join the action: http://www.zlk.com/martek-matk.html, or call: 877-363-5972.

The investigation concerns whether the Martek Board of Directors breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before entering into this transaction and whether DSM is underpaying for Martek shares, thus unlawfully harming Martek stockholders.

If you own common stock in Martek and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/martek-matk.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

1 Year Martek Chart

1 Year Martek Chart

1 Month Martek Chart

1 Month Martek Chart

Your Recent History

Delayed Upgrade Clock